High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of Efficacy
Background: Botulinum neurotoxin therapy (BoNT) is a powerful tool for treating many neurologic disorders. The U.S. Food and Drug Administration (FDA)-approved maximum onabotulinum toxin A (OnaA) dose is 400 units (U) per visit, but higher doses are commonly necessary, particularly when treating mul...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ubiquity Press
2020-02-01
|
| Series: | Tremor and Other Hyperkinetic Movements |
| Subjects: | |
| Online Access: | https://tremorjournal.org/index.php/tremor/article/view/749/2581 |